Cardiovascular Systems Reports Fiscal 2016 First-Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street lower on AI spending jitters; oil prices rebound
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
Cardiovascular Systems (CSII) Guides Low 2Q16 Given Lingering Headwinds; Needham & Company Reiterates Buy
November 5, 2015 7:12 AM ESTNeedham & Company reiterated a Buy rating on Cardiovascular Systems (NASDAQ: CSII), and raised the price target to $19.00 (from $18.00), following the company's 1Q16 earnings report. Revenue was $43.9M (up 11% Y/Y after accounting for the end of the Asahi distribution agreement) vs. guidance of $43.9M and EPS was... More
Cardiovascular Systems (CSII) Tops Q1 EPS by 1c
November 4, 2015 4:25 PM ESTCardiovascular Systems (NASDAQ: CSII) reported Q1 EPS of ($0.41), $0.01 better than the analyst estimate of ($0.42). Revenue for the quarter came in at $43.9 million versus the consensus estimate of $43.9 million.
For earnings history and earnings-related data on Cardiovascular Systems (CSII) click here.
... More


